Healthcare & Life Sciences
Arthrosi
United Statesarthrosi.com/
Arthrosi is a Healthcare & Life Sciences startup based in the United States, most recent round Series C, 2 tracked investors.
Activeseries-c
series-c
Stage
2
Investors
About Arthrosi
Based in the United States, Arthrosi is a startup. Its most recent tracked round is Series C. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Arthrosi is a clinical-stage biotechnology company developing AR882, a drug candidate for lowering urate levels and treating gout, including patients with renal impairment and chronic kidney disease.
Explore Arthrosi's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.